First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials

Joerg J. Moehrle, Stephan Duparc, Christoph Siethoff, Paul L.M. van Giersbergen, J. Carl Craft, Sarah Arbe-Barnes, Susan A. Charman, Maria Gutierrez, Sergio Wittlin, Jonathan L. Vennerstrom

Research output: Contribution to journalArticlepeer-review

81 Scopus citations

Fingerprint

Dive into the research topics of 'First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials'. Together they form a unique fingerprint.

Medicine & Life Sciences